Role of CMR imaging in risk stratification for sudden cardiac death

JACC: Cardiovascular Imaging

Volumn 6, Issue 3, 2013, Pages 392-406

  Aljaroudi, Wael A ^a   Flamm, Scott D ^a   Saliba, Walid ^a   Wilkoff, Bruce L ^a   Kwon, Deborah ^a  

^a LERNER RESEARCH INSTITUTE   (United States)

Author keywords

CMR; risk stratification; sudden cardiac death

Indexed keywords

ARTICLE; CARDIOVASCULAR MAGNETIC RESONANCE; CARDIOVASCULAR RISK; HEART INFARCTION; HEART LEFT VENTRICLE EJECTION FRACTION; HEART MUSCLE INJURY; HEART MUSCLE SCAR; HIGH RISK PATIENT; IMPLANTABLE CARDIOVERTER DEFIBRILLATOR; ISCHEMIC CARDIOMYOPATHY; LEFT VENTRICULAR SYSTOLIC DYSFUNCTION; MYOCARDITIS; PRIORITY JOURNAL; PROGNOSIS; RISK ASSESSMENT; SCAR; SUDDEN DEATH;

EID: 84875335573     PISSN: 1936878X     EISSN: 18767591     Source Type: Journal    
DOI: 10.1016/j.jcmg.2012.11.011     Document Type: Review

References (97)

1. A.E. Epstein, J.P. DiMarco, K.A. Ellenbogen ACC/AHA/HRS 2008 guidelines for device-based therapy of cardiac rhythm abnormalities: A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the ACC/AHA/NASPE 2002 Guideline Update for Implantation of Cardiac Pacemakers and Antiarrhythmia Devices) developed in collaboration with the American Association for Thoracic Surgery and Society of Thoracic Surgeons J Am Coll Cardiol 51 2008 e1 e62
2. G.H. Bardy, K.L. Lee, D.B. Mark Sudden Cardiac Death in Heart Failure Trial (SCD-HeFT) Investigators Amiodarone or an implantable cardioverter- defibrillator for congestive heart failure N Engl J Med 352 2005 225 237
3. A.E. Buxton, K.L. Lee, G.E. Hafley Limitations of ejection fraction for prediction of sudden death risk in patients with coronary artery disease: Lessons from the MUSTT study J Am Coll Cardiol 50 2007 1150 1157
4. T.J. Wu, J.J. Ong, C. Hwang Characteristics of wave fronts during ventricular fibrillation in human hearts with dilated cardiomyopathy: Role of increased fibrosis in the generation of reentry J Am Coll Cardiol 32 1998 187 196
5. J.C. Moon, E. Reed, M.N. Sheppard The histologic basis of late gadolinium enhancement cardiovascular magnetic resonance in hypertrophic cardiomyopathy J Am Coll Cardiol 43 2004 2260 2264
6. A. Wagner, H. Mahrholdt, T.A. Holly Contrast-enhanced MRI and routine single photon emission computed tomography (SPECT) perfusion imaging for detection of subendocardial myocardial infarcts: an imaging study Lancet 361 2003 374 379
7. L. Iles, H. Pfluger, A. Phrommintikul Evaluation of diffuse myocardial fibrosis in heart failure with cardiac magnetic resonance contrast-enhanced T1 mapping J Am Coll Cardiol 52 2008 1574 1580
8. A.S. Flett, M.P. Hayward, M.T. Ashworth Equilibrium contrast cardiovascular magnetic resonance for the measurement of diffuse myocardial fibrosis: preliminary validation in humans Circulation 122 2010 138 144
9. E. Dall'Armellina, S.K. Piechnik, V.M. Ferreira Cardiovascular magnetic resonance by non contrast T1-mapping allows assessment of severity of injury in acute myocardial infarction J Cardiovasc Magn Reson 14 2012 15
10. D.R. Messroghli, A. Radjenovic, S. Kozerke, D.M. Higgins, M.U. Sivananthan, J.P. Ridgway Modified Look-Locker inversion recovery (MOLLI) for high-resolution T1 mapping of the heart Magn Reson Med 52 2004 141 146
11. R.J. Kim, E.L. Chen, J.A. Lima, R.M. Judd Myocardial Gd-DTPA kinetics determine MRI contrast enhancement and reflect the extent and severity of myocardial injury after acute reperfused infarction Circulation 94 1996 3318 3326
12. R.J. Kim, D.S. Fieno, T.B. Parrish Relationship of MRI delayed contrast enhancement to irreversible injury, infarct age, and contractile function Circulation 100 1999 1992 2002
13. R.J. Kim, E. Wu, A. Rafael The use of contrast-enhanced magnetic resonance imaging to identify reversible myocardial dysfunction N Engl J Med 343 2000 1445 1453
14. A.S. Flett, J. Hasleton, C. Cook Evaluation of techniques for the quantification of myocardial scar of differing etiology using cardiac magnetic resonance J Am Coll Cardiol Img 4 2011 150 156
15. A.T. Yan, A.J. Shayne, K.A. Brown Characterization of the peri-infarct zone by contrast-enhanced cardiac magnetic resonance imaging is a powerful predictor of post-myocardial infarction mortality Circulation 114 2006 32 39
16. P. Gao, L. Gula, R. Yee Prediction of arrhythmic events in ischemic and dilated cardiomyopathy patients referred for implantable cardiac defibrillator: Evaluation of multiple scar quantification measures for late gadolinium enhancement magnetic resonance imaging Circ Cardiovasc Imaging 5 2012 448 456
17. M.P. Turakhia, N.B. Schiller, M.A. Whooley Prognostic significance of increased left ventricular mass index to mortality and sudden death in patients with stable coronary heart disease (from the Heart and Soul Study) Am J Cardiol 102 2008 1131 1135
18. D. Bello, D.S. Fieno, R.J. Kim Infarct morphology identifies patients with substrate for sustained ventricular tachycardia J Am Coll Cardiol 45 2005 1104 1108
19. A. Schmidt, C.F. Azevedo, A. Cheng Infarct tissue heterogeneity by magnetic resonance imaging identifies enhanced cardiac arrhythmia susceptibility in patients with left ventricular dysfunction Circulation 115 2007 2006 2014
20. S. de Haan, T.A. Meijers, P. Knaapen, A.M. Beek, A.C. van Rossum, C.P. Allaart Scar size and characteristics assessed by CMR predict ventricular arrhythmias in ischaemic cardiomyopathy: Comparison of previously validated models Heart 97 2011 1951 1956
21. S.D. Roes, C.J. Borleffs, R.J. van der Geest Infarct tissue heterogeneity assessed with contrast-enhanced MRI predicts spontaneous ventricular arrhythmia in patients with ischemic cardiomyopathy and implantable cardioverter- defibrillator Circ Cardiovasc Imaging 2 2009 183 190
22. I. Klem, J.W. Weinsaft, T.D. Bahnson Assessment of myocardial scarring improves risk stratification in patients evaluated for cardiac defibrillator implantation J Am Coll Cardiol 60 2012 408 420
23. K.C. Wu, G. Gerstenblith, E. Guallar Combined cardiac magnetic resonance imaging and C-reactive protein levels identify a cohort at low risk for defibrillator firings and death Circ Cardiovasc Imaging 5 2012 178 186
24. K.H. Haugaa, M.K. Smedsrud, T. Steen Mechanical dispersion assessed by myocardial strain in patients after myocardial infarction for risk prediction of ventricular arrhythmia J Am Coll Cardiol Img 3 2010 247 256
25. R.G. Assomull, S.K. Prasad, J. Lyne Cardiovascular magnetic resonance, fibrosis, and prognosis in dilated cardiomyopathy J Am Coll Cardiol 48 2006 1977 1985
26. J.M. de Bakker, F.J. van Capelle, M.J. Janse Slow conduction in the infarcted human heart. 'Zigzag' course of activation Circulation 88 1993 915 926
27. J.P. Daubert, W. Zareba, W.J. Hall Predictive value of ventricular arrhythmia inducibility for subsequent ventricular tachycardia or ventricular fibrillation in Multicenter Automatic Defibrillator Implantation Trial (MADIT) II patients J Am Coll Cardiol 47 2006 98 107
28. S. Nazarian, D.A. Bluemke, A.C. Lardo Magnetic resonance assessment of the substrate for inducible ventricular tachycardia in nonischemic cardiomyopathy Circulation 112 2005 2821 2825
29. L. Iles, H. Pfluger, L. Lefkovits Myocardial fibrosis predicts appropriate device therapy in patients with implantable cardioverter- defibrillators for primary prevention of sudden cardiac death J Am Coll Cardiol 57 2011 821 828
30. K.C. Wu, R.G. Weiss, D.R. Thiemann Late gadolinium enhancement by cardiovascular magnetic resonance heralds an adverse prognosis in nonischemic cardiomyopathy J Am Coll Cardiol 51 2008 2414 2421
31. C.J. McLeod, S.R. Ommen, M.J. Ackerman Surgical septal myectomy decreases the risk for appropriate implantable cardioverter defibrillator discharge in obstructive hypertrophic cardiomyopathy Eur Heart j 28 2007 2583 2588
32. R.A. Leonardi, E.P. Kransdorf, D.L. Simel, A. Wang Meta-analyses of septal reduction therapies for obstructive hypertrophic cardiomyopathy: Comparative rates of overall mortality and sudden cardiac death after treatment Circ Cardiovasc Interv 3 2010 97 104
33. F.J. ten Cate, O.I. Soliman, M. Michels Long-term outcome of alcohol septal ablation in patients with obstructive hypertrophic cardiomyopathy: A word of caution Circ Heart Fail 3 2010 362 369
34. S. Leonardi, C. Raineri, G.M. De Ferrari Usefulness of cardiac magnetic resonance in assessing the risk of ventricular arrhythmias and sudden death in patients with hypertrophic cardiomyopathy Eur Heart J 30 2009 2003 2010
35. L.L. Cregler Progression from hypertrophic cardiomyopathy to dilated cardiomyopathy J Natl Med Assoc 81 1989 820 824-6
36. S. Fluechter, J. Kuschyk, C. Wolpert Extent of late gadolinium enhancement detected by cardiovascular magnetic resonance correlates with the inducibility of ventricular tachyarrhythmia in hypertrophic cardiomyopathy J Cardiovasc Magn Reson 12 2010 30
37. J.J. Green, J.S. Berger, C.M. Kramer, M. Salerno Prognostic value of late gadolinium enhancement in clinical outcomes for hypertrophic cardiomyopathy J Am Coll Cardiol Img 5 2012 370 377
38. R. Chan, B.J. Maron, I. Olovotto Prognostic utility of contrast-enhanced cardiovascular magnetic resonance in hypertrophic cardiomyopathy: an international multicenter study J Am Coll Cardiol 59 2012 E1570
39. O. Bruder, A. Wagner, C.J. Jensen Myocardial scar visualized by cardiovascular magnetic resonance imaging predicts major adverse events in patients with hypertrophic cardiomyopathy J Am Coll Cardiol 56 2010 875 887
40. L.A. Mendes, G.W. Dec, M.H. Picard, I.F. Palacios, J. Newell, R. Davidoff Right ventricular dysfunction: an independent predictor of adverse outcome in patients with myocarditis Am Heart J 128 1994 301 307
41. S. Grun, J. Schumm, S. Greulich Long-term follow-up of biopsy-proven viral myocarditis: predictors of mortality and incomplete recovery J Am Coll Cardiol 59 2012 1604 1615
42. R. Hamilton, L. Sullivan, B. Wolf Sudden cardiac death due to giant cell inflammatory processes J Forensic Sci 52 2007 943 948
43. M.A. Rossi Fibrosis and inflammatory cells in human chronic chagasic myocarditis: scanning electron microscopy and immunohistochemical observations Int J Cardiol 66 1998 183 194
44. A.V. Sarabanda, J.A. Marin-Neto Predictors of mortality in patients with Chagas' cardiomyopathy and ventricular tachycardia not treated with implantable cardioverter-defibrillators Pacing Clin Electrophysiol 34 2011 54 62
45. C.E. Rochitte, P.F. Oliveira, J.M. Andrade Myocardial delayed enhancement by magnetic resonance imaging in patients with Chagas' disease: A marker of disease severity J Am Coll Cardiol 46 2005 1553 1558
46. N. Pablo, L. Eugene, B. David Arrhythmias in cardiac sarcoidosis: diagnosis and treatment Curr Opin Cardiol 27 2012 181 189
47. M.R. Patel, P.J. Cawley, J.F. Heitner Detection of myocardial damage in patients with sarcoidosis Circulation 120 2009 1969 1977
48. D. Mehta, N. Mori, S.H. Goldbarg, S. Lubitz, J.P. Wisnivesky, A. Teirstein Primary prevention of sudden cardiac death in silent cardiac sarcoidosis: Role of programmed ventricular stimulation Circ Arrhythm Electrophysiol 4 2011 43 48
49. A. Aizer, E.H. Stern, J.A. Gomes, A.S. Teirstein, R.E. Eckart, D. Mehta Usefulness of programmed ventricular stimulation in predicting future arrhythmic events in patients with cardiac sarcoidosis Am J Cardiol 96 2005 276 282
50. N.I. Stauder, B. Bader, M. Fenchel, U. Kramer, V. Kuhlkamp, S. Miller Images in cardiovascular medicine Follow-up of cardiac sarcoidosis by magnetic resonance imaging Circulation 111 2005 e158 e160
51. F.I. Marcus, W.J. McKenna, D. Sherrill Diagnosis of arrhythmogenic right ventricular cardiomyopathy/dysplasia: proposed modification of the task force criteria Circulation 121 2010 1533 1541
52. A. Bhonsale, C.A. James, C. Tichnell Incidence and predictors of implantable cardioverter-defibrillator therapy in patients with arrhythmogenic right ventricular dysplasia/cardiomyopathy undergoing implantable cardioverter-defibrillator implantation for primary prevention J Am Coll Cardiol 58 2011 1485 1496
53. H. Tandri, M. Saranathan, E.R. Rodriguez Noninvasive detection of myocardial fibrosis in arrhythmogenic right ventricular cardiomyopathy using delayed-enhancement magnetic resonance imaging J Am Coll Cardiol 45 2005 98 103
54. A. Mekinian, C. Lions, X. Leleu Prognosis assessment of cardiac involvement in systemic AL amyloidosis by magnetic resonance imaging Am J Med 123 2010 864 868
55. R.H. Falk, A. Rubinow, A.S. Cohen Cardiac arrhythmias in systemic amyloidosis: Correlation with echocardiographic abnormalities J Am Coll Cardiol 3 1984 107 113
56. S.W. Dubrey, S. Bilazarian, M. LaValley, J. Reisinger, M. Skinner, R.H. Falk Signal-averaged electrocardiography in patients with AL (primary) amyloidosis Am Heart J 134 1997 994 1001
57. D.J. Pennell T2* magnetic resonance and myocardial iron in thalassemia Ann N Y Acad Sci 1054 2005 373 378
58. P. Kirk, M. Roughton, J.B. Porter Cardiac T2* magnetic resonance for prediction of cardiac complications in thalassemia major Circulation 120 2009 1961 1968
59. J.C. Moon, M. Sheppard, E. Reed, P. Lee, P.M. Elliott, D.J. Pennell The histological basis of late gadolinium enhancement cardiovascular magnetic resonance in a patient with Anderson-Fabry disease J Cardiovasc Magn Reson 8 2006 479 482
60. T. Walcher, P. Steinbach, J. Spiess Detection of long-term progression of myocardial fibrosis in Duchenne muscular dystrophy in an affected family: A cardiovascular magnetic resonance study Eur J Radiol 80 2011 115 119
61. K.C. Bilchick, M. Salerno, D. Plitt Prevalence and distribution of regional scar in dysfunctional myocardial segments in Duchenne muscular dystrophy J Cardiovasc Magn Reson 13 2011 20
62. A. Yilmaz, H.J. Gdynia, H. Baccouche Cardiac involvement in patients with Becker muscular dystrophy: New diagnostic and pathophysiological insights by a CMR approach J Cardiovasc Magn Reson 10 2008 50
63. A. Yanagisawa, M. Miyagawa, M. Yotsukura The prevalence and prognostic significance of arrhythmias in Duchenne type muscular dystrophy Am Heart J 124 1992 1244 1250
64. G. Leurent, A.E. Baruteau, A. Larralde Contribution of cardiac MRI in the comprehension of peripartum cardiomyopathy pathogenesis Int J Cardiol 132 2009 e91 e93
65. S. Murali, M.R. Baldisseri Peripartum cardiomyopathy Crit Care Med 33 2005 S340 S346
66. C.N. Ionescu, C.A. Aguilar-Lopez, A.E. Sakr, A.E. Ghantous, T.J. Donohue Long-term outcome of Tako-tsubo cardiomyopathy Heart Lung Circ 19 2010 601 605
67. M.N. Bellera, J.T. Ortiz, M.T. Caralt Magnetic resonance reveals long-term sequelae of apical ballooning syndrome Int J Cardiol 139 2010 25 31
68. M.T. Saltzberg, S. Szymkiewicz, N.R. Bianco Characteristics and outcomes of peripartum versus nonperipartum cardiomyopathy in women using a wearable cardiac defibrillator J Card Fail 18 2012 21 27
69. B.J. Maron, P.D. Thompson, M.J. Ackerman Recommendations and considerations related to preparticipation screening for cardiovascular abnormalities in competitive athletes: 2007 update: A scientific statement from the American Heart Association Council on Nutrition, Physical Activity, and Metabolism: Endorsed by the American College of Cardiology Foundation Circulation 115 2007 1643-455
70. B.J. Maron, A. Pelliccia The heart of trained athletes: Cardiac remodeling and the risks of sports, including sudden death Circulation 114 2006 1633 1644
71. N.H. Prakken, B.K. Velthuis, M.J. Cramer, A. Mosterd Advances in cardiac imaging: The role of magnetic resonance imaging and computed tomography in identifying athletes at risk Br J Sports Med 43 2009 677 684
72. R.A. Krasuski, D. Magyar, S. Hart Long-term outcome and impact of surgery on adults with coronary arteries originating from the opposite coronary cusp Circulation 123 2011 154 162
73. N. Mousavi, A. Czarnecki, K. Kumar Relation of biomarkers and cardiac magnetic resonance imaging after marathon running Am J Cardiol 103 2009 1467 1472
74. D.G. Strauss, K.C. Wu Imaging myocardial scar and arrhythmic risk prediction - a role for the electrocardiogram? J Electrocardiol 42 2009 138 e1-8
75. J.J. Goldberger, M.E. Cain, S.H. Hohnloser et al. American Heart Association/American College of Cardiology Foundation/Heart Rhythm Society Scientific Statement on Noninvasive Risk Stratification Techniques for Identifying Patients at Risk for Sudden Cardiac Death A scientific statement from the American Heart Association Council on Clinical Cardiology Committee on Electrocardiography and Arrhythmias and Council on Epidemiology and Prevention J Am Coll Cardiol 52 2008 1179 1199
76. T. Tsuji, H. Tanaka, K. Matsumoto Capability of three-dimensional speckle tracking radial strain for identification of patients with cardiac sarcoidosis Int J Cardiovasc Imaging Img 29 2013 317 324
77. G.H. Yan, M. Wang, K.H. Yiu Subclinical left ventricular dysfunction revealed by circumferential 2D strain imaging in patients with coronary artery disease and fragmented QRS complex Heart Rhythm 9 2012 928 935
78. E. Correia, B. Rodrigues, L.F. Santos Longitudinal left ventricular strain in hypertrophic cardiomyopathy: Correlation with nonsustained ventricular tachycardia Echocardiography 28 2011 709 714
79. K.H. Yiu, A.A. Schouffoer, N.A. Marsan Left ventricular dysfunction assessed by speckle-tracking strain analysis in patients with systemic sclerosis: Relationship to functional capacity and ventricular arrhythmias Arthritis Rheum 63 2011 3969 3978
80. A.W. Ahlberg, F.A. Kazi, T. Azemi Usefulness of stress gated technetium-99m single photon emission computed tomographic myocardial perfusion imaging for the prediction of cardiac death in patients with moderate to severe left ventricular systolic dysfunction and suspected coronary artery disease Am J Cardiol 109 2012 26 30
81. W.A. Aljaroudi, F.G. Hage, D. Hermann Relation of left-ventricular dyssynchrony by phase analysis of gated SPECT images and cardiovascular events in patients with implantable cardiac defibrillators J Nucl Cardiol 17 2010 398 404
82. G. Youssef, E. Leung, I. Mylonas The use of 18F-FDG PET in the diagnosis of cardiac sarcoidosis: A systematic review and metaanalysis including the Ontario experience J Nucl Med 53 2012 241 248
83. M.J. Boogers, C.J. Borleffs, M.M. Henneman Cardiac sympathetic denervation assessed with 123-iodine metaiodobenzylguanidine imaging predicts ventricular arrhythmias in implantable cardioverter-defibrillator patients J Am Coll Cardiol 55 2010 2769 2777
84. A.H. Kadish, D. Bello, J.P. Finn Rationale and design for the Defibrillators to Reduce Risk by Magnetic Resonance Imaging Evaluation (DETERMINE) trial J Cardiovasc Electrophysiol 20 2009 982 987
85. R. Passman, J.J. Goldberger Predicting the future: Risk stratification for sudden cardiac death in patients with left ventricular dysfunction Circulation 125 2012 3031 3037
86. I. Goldenberg, J. Gillespie, A.J. Moss Long-term benefit of primary prevention with an implantable cardioverter-defibrillator: an extended 8-year follow-up study of the Multicenter Automatic Defibrillator Implantation Trial II Circulation 122 2010 1265 1271
87. P. Kirchhof, G. Breithardt, L. Eckardt Primary prevention of sudden cardiac death Heart 92 2006 1873 1878
88. J.B. van Rees, C.J. Borleffs, M.K. de Bie Inappropriate implantable cardioverter-defibrillator shocks: Incidence, predictors, and impact on mortality J Am Coll Cardiol 57 2011 556 562
89. K.H. Schuleri, M. Centola, R.T. George Characterization of peri-infarct zone heterogeneity by contrast-enhanced multidetector computed tomography: A comparison with magnetic resonance imaging J Am Coll Cardiol 53 2009 1699 1707
90. E.B. Schelbert, L.Y. Hsu, S.A. Anderson Late gadolinium-enhancement cardiac magnetic resonance identifies postinfarction myocardial fibrosis and the border zone at the near cellular level in ex vivo rat heart Circ Cardiovasc Imaging 3 2010 743 752
91. T. Reiter, O. Ritter, M.R. Prince Minimizing Risk of Nephrogenic systemic fibrosis in Cardiovascular Magnetic Resonance J Cardiovasc Magn Reson 14 2012 31
92. N. Kawel, M. Nacif, A. Zavodni T1 mapping of the myocardium: Intra-individual assessment of post-contrast T1 time evolution and extracellular volume fraction at 3T for Gd-DTPA and Gd-BOPTA J Cardiovasc Magn Reson 14 2012 26
93. G. Korosoglou, G. Gitsioudis, A. Voss Strain-encoded cardiac magnetic resonance during high-dose dobutamine stress testing for the estimation of cardiac outcomes: Comparison to clinical parameters and conventional wall motion readings J Am Coll Cardiol 58 2011 1140 1149
94. W. Jung, V. Zvereva, B. Hajredini, S. Jackle Safe magnetic resonance image scanning of the pacemaker patient: Current technologies and future directions Reply to the Letter by Dr. Nordbeck, Dr. Bauer, and Dr. Ritter Europace 14 2012 1532 1533
95. M.J. Junttila, J.E. Fishman, G.A. Lopera Safety of serial MRI in patients with implantable cardioverter defibrillators Heart 97 2011 1852 1856
96. C.P. Naehle, J. Kreuz, K. Strach Safety, feasibility, and diagnostic value of cardiac magnetic resonance imaging in patients with cardiac pacemakers and implantable cardioverters/defibrillators at 1.5 T Am Heart J 161 2011 1096 1105
97. D. Verhaert, P. Thavendiranathan, S. Giri Direct T2 quantification of myocardial edema in acute ischemic injury J Am Coll Cardiol Img 4 2011 269 278